HEMATOPOIETIC CELL TRANSPLANTATION: A Curative Option for Sickle Cell Disease

REFERENCES

• Platt OS, Brambilla DJ, Rosse WF. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639–1644
   PubMed Web of Science ®Google Scholar
• Benton TD, Ifeagwu JA, Smith-Whitley K. Anxiety and depression in children and adolescents with sickle cell disease. Curr Psychiatry Rep 2007; 9: 114–121
   PubMedGoogle Scholar
• McClish DK, Penberthy LT, Bovbjerg VE. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes 2005; 3: 50
   PubMedGoogle Scholar
• Walters M C, Patience M, Leisenring W. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376
   PubMed Web of Science ®Google Scholar
• Walters M C, Storb R, Patience M. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000; 95: 1918–1924
   PubMed Web of Science ®Google Scholar
• Vermylen C, Cornu G, Ferster A. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1–6
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Socie G, Kuentz M. Long-term results of related, myeloablative stem cell transplantation to cure sickle cell disease. Blood 2007; 110(7): 2746–2756
   Google Scholar
• Walters M C, Storb R, Patience M. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report: multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918–1924
   PubMed Web of Science ®Google Scholar
• Abboud M R, Jackson S M, Barredo J, Beatty J, Laver J. Bone marrow transplantation for sickle cell anemia. Am J Pediatr Hematol Oncol 1994; 16: 86–89
   PubMedGoogle Scholar
• Giardini C, Galimberti M, Lucarelli G. Bone marrow transplantation in sickle-cell anemia in Pesaro. Bone Marrow Transplant 1993; 12: 122–123
   PubMed Web of Science ®Google Scholar
• Panepinto J A, Walters M C, Carreras J. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol 2007; 137: 479–485
   PubMed Web of Science ®Google Scholar
• Walters MC. Sickle cell anemia and hematopoietic cell transplantation: When is a pound of cure worth more than an ounce of prevention?. Pediatr Transplant 2004; 8(Suppl 5)33–38
   PubMed Web of Science ®Google Scholar
• Ferster A, Bujan W, Corazza F. Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood 1993; 81: 1102–1105
   PubMed Web of Science ®Google Scholar
• Eggleston B, Patience M, Edwards S. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol 2007; 136: 673–676
   PubMed Web of Science ®Google Scholar
• Reed W, Smith R, Dekovic F. Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood 2003; 101: 351–357
   PubMed Web of Science ®Google Scholar
• Brichard B, Vermylen C, Ninane J, Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 1996; 128: 241–243
   PubMed Web of Science ®Google Scholar
• Gore L, Lane P A, Quinones R R, Giller R H. Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care. J Pediatr Hematol Oncol 2000; 22: 437–440
   PubMed Web of Science ®Google Scholar
• Locatelli F, Rocha V, Reed W. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143
   PubMed Web of Science ®Google Scholar
• Chakraverty R, Peggs K, Chopra R. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002; 99: 1071–1078
   PubMed Web of Science ®Google Scholar
• Adamkiewicz T V, Mehta P S, Boyer M W. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 2004; 34: 405–411
   PubMed Web of Science ®Google Scholar
• Adamkiewicz T V, Szabolcs P, Haight A. Unrelated cord blood transplantation in children with sickle cell disease: review of four centers experience. Pediatr Transplant 2007; 11(6): 641–644
   Web of Science ®Google Scholar
• Werner E, Yanovich S, Rubinstein P, Kurtzberg J. Unrelated placental cord blood transplantation in a patient with sickle cell disease and acute non-lymphocytic leukemia. Blood 1997; 90(399b)
   Google Scholar
• La Nasa G, Giardini C, Locatelli F. Unrelated bone marrow transplantation in thalassemia: the experience of the Italian Bone Marrow Transplant Group (GITMO). Haematologica 2002; 87(8 Suppl)58–61
   PubMedGoogle Scholar
• Storb R F, Lucarelli G, McSweeney P A, Childs R W. Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematology (Am Soc Hematol Educ Program) 2003; 372–397
   PubMedGoogle Scholar
• Krishnamurti L, Blazar B R, Wagner J E. Bone marrow transplantation without myeloablation for sickle cell disease. N Engl J Med 2001; 344: 68
   PubMed Web of Science ®Google Scholar
• Krishnamurti L, Wu C J, Baker K S, Wagner J E. Matched sibling donor hematopoietic cell transplantation for sickle cell disease using a reduced intensity conditioning regimen can lead to stable long term engraftment. Blood 2005; 106. Abstract 3172
   Google Scholar
• Schleuning M, Stoetzer O, Waterhouse C, Schlemmer M, Ledderose G, Kolb H J. Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp Hematol 2002; 30: 7–10
   PubMed Web of Science ®Google Scholar
• Shenoy S, Grossman W J, DiPersio J. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005; 35: 345–352
   PubMed Web of Science ®Google Scholar
• van Besien K, Bartholomew A, Stock W. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant 2000; 26: 445–449
   PubMed Web of Science ®Google Scholar
• Mazur M, Kurtzberg J, Halperin E, Ciocci G, Szabolcs P. Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. J Pediatr Hematol Oncol. 2006; 28: 840–844
   PubMed Web of Science ®Google Scholar
• Horan J T, Liesveld J L, Fenton P, Blumberg N, Walters M C. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant 2005; 35: 171–177
   PubMed Web of Science ®Google Scholar
• Iannone R, Casella J F, Fuchs E J. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003; 9: 519–528
   PubMed Web of Science ®Google Scholar
• Woolfrey A E, Pulsipher M A, Storb R. Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children. Int J Hematol 2002; 76(Suppl 2)271–277
   PubMed Web of Science ®Google Scholar
• Walters M C, Patience M, Leisenring W. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100–104
   PubMedGoogle Scholar
• Chakrabarti S, Bareford D. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 2007; 39: 447–451
   PubMed Web of Science ®Google Scholar
• Kodish E, Lantos J, Siegler M, Kohrman A, Johnson F L. Bone marrow transplantation in sickle cell disease: the trade-off between early mortality and quality of life. Clin Res 1990; 38: 694–700
   PubMedGoogle Scholar
• Kodish E, Lantos J, Stocking C, Singer P A, Siegler M, Johnson F L. Bone marrow transplantation for sickle cell disease: a study of parents' decisions. N Engl J Med 1991; 325: 1349–1353
   PubMed Web of Science ®Google Scholar
• van Besien K, Koshy M, Anderson-Shaw L. Allogeneic stem cell transplantation for sickle cell disease: a study of patients' decisions. Bone Marrow Transplant 2001; 28: 545–549
   PubMed Web of Science ®Google Scholar
• Sebastiani P, Nolan V G, Baldwin C T. A network model to predict the risk of death in sickle cell disease. Blood 2007; 110(7): 2727–2735
   Google Scholar
• Steinberg M H, Barton F, Castro O. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003; 289: 1645–1651
   PubMed Web of Science ®Google Scholar
• Fung E B, Harmatz P, Milet M. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. Am J Hematol 2007; 82: 255–265
   PubMed Web of Science ®Google Scholar
• Vichinsky E, Onyekwere O, Porter J. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol 2007; 136: 501–508
   PubMed Web of Science ®Google Scholar
• Gladwin M T, Kato G J. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematol Am Soc Hematol Educ Program 2005; 51–57
   PubMedGoogle Scholar
• Wong W Y, Powars DR. Overt and incomplete (silent) cerebral infarction in sickle cell anemia: diagnosis and management. Hematol Oncol Clin North Am 2005; 19: 839–855, vi
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans M M, Demylle D. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report. Hum Reprod 2006; 21: 183–188
   PubMed Web of Science ®Google Scholar
• Walters M C, Sullivan K M, Bernaudin F. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 1995; 85: 879–884
   PubMed Web of Science ®Google Scholar